# Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

> **NCT01283204** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 180 (actual)

## Conditions studied

- Recurrent or Metastatic Gastric Cancer

## Interventions

- **DRUG:** SP
- **DRUG:** FL/Tax
- **DRUG:** FL/Doc
- **DRUG:** FOLFOX

## Key facts

- **NCT ID:** NCT01283204
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-09
- **Primary completion:** 2016-07-25
- **Final completion:** 2016-07-25
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2019-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283204, "Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01283204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*